In xenograft models, this carotenoid administered at the dose of 200 mg/kg for 28 days showed antiproliferative and proapoptotic effects as well as reduced invasion and migration in a xenograft of glioblastoma through suppression of PI3K/Akt/mTOR and p38 pathways [364]. This evidence concerns the gene AKT1 and glioblastoma.